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Abstract Candida sp. have been responsible for an increasing
numberofinfections,especially inpatientswithimmunodeficiency.
Species-specific differentiationofCandida sp. is difficult in routine
diagnosis. This identification can have a highly significant associa-
tion in therapy and prophylaxis. Thiswork has shown a newappli-
cation of the terminal restriction fragment length polymorphism (t-
RFLP) method in the molecular identification of six species of
Candida, which are themost common causes of fungal infections.
Specific for fungi homocitrate synthase gene was chosen as a mo-
lecular target foramplification.Theuseofthreerestrictionenzymes,
DraI,RsaI, andBglII, for amplicon digestion can generate species-
specific fluorescence labeledDNAfragmentprofiles,whichcanbe
used to determine the diagnostic algorithm. The designed method
can be a cost-efficient high-throughputmolecular technique for the
identification of six clinically importantCandida species.
Keywords Candida . t-RFLP . PCR . Homocitrate synthase
gene .Molecular diagnostic
Introduction
Fungal infections of the Candida sp. etiology are a serious
clinical problem. The mortality of candidemia episodes
exceeds 50%. Furthermore, there are many factors which
make this infection more and more dangerous, such as devel-
opment of drug resistance, immunosuppressive therapies, di-
abetes, and increasing number of cancer incidence (López-
Martínez 2010). The treatment of infection varies depending
on its etiological agents (Miceli et al. 2011). This is the main
reason why rapid and accurate diagnosis is needed. Natural
antibiotics resistance differs among Candida species, which
makes it crucial to know which species are going to be dealt
with (e.g., fluconazole resistance of C. glabrata and C. krusei,
which is the first-line antifungal treatment) (Tortorano et al.
2004). Correct therapy based on fast and reliable diagnosis is
essential to treat patients successfully and to decrease
mortality.
Opportunistic fungal infections in immunocompromised
hosts are caused mainly by Candida species, and the majority
of such infections are due toC. albicans (Silveira-Gomes et al.
2011), which shares many phenotypic features with
C. dubliniensis, and may, therefore, be misidentified in clini-
cal microbiology laboratories. Species-specific differentiation
of the two closely related yeasts, C. albicans and
C. dubliniensis, is difficult in routine diagnosis. Reliable, rou-
tinely applicable methods for species-specific differentiation
of C. albicans and C. dubliniensis appear to be of particular
importance to better understand the epidemiology and viru-
lence ofC. dubliniensis (Hof et al. 2012). Candidemias caused
by C. dubliniensis have been increasingly reported in recent
years (Ahmad et al. 2012).
Methods for the identification of Candida sp. can be divid-
ed into conventional and molecular techniques. Conventional
methods are based on the germ tube test, chlamydospore for-
mation, and the fermentation or assimilation of sugars (Alam
et al. 2014). There are also several chromogenic media for the
isolation and identification of Candida species (Letscher-Bru
et al. 2002). Colonies growing on these media have different
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morphology and color as a result from the cleavage of chro-
mogenic substrates by species-specific enzymes (Bauters and
Nelis 2002). However, the colors of colonies of one species
may differ depending on the strain and may lead to misiden-
tification (Ozcan et al. 2010). Methods for Candida identifi-
cation can also be divided into non-DNA- and DNA-based
techniques. In the group of non-DNA-based methods, there
are such identification tests as serological [latex agglutination,
enzyme-linked immunosorbent assay (ELISA), immunoblot-
ting, dot immunoassay, liposomal immunoassay, and radioim-
munoassay (RIA) (Ponton et al. 2002)] and spectroscopic
methods (Manzoor et al. 2016). A very large and still fast
developing group of methods are DNA-based techniques.
They are mostly based on different types of polymerase chain
reaction (PCR): microsatellite typing (Zane et al. 2002),
multilocus sequence typing (MLST) (Odds 2010), randomly
amplified polymorphic DNA (RAPD) (Melo et al. 1998), sim-
plex PCR (Trtkova and Raclavsky 2006), multiplex PCR (Lau
et al. 2008), nested PCR (Kanbe et al. 2002), real-time PCR
(Fricke et al. 2010; Olchawa et al. 2013), and restriction frag-
ment length polymorphism (RFLP) (de Llanos Frutos et al.
2004). The latter method as the terminal restriction fragment
length polymorphism (t-RFLP) method is used for the
genotyping and study of microbial diversity and microorgan-
isms community structure in different environmental samples
(Osborn et al. 2000; Schütte et al. 2008; Zhang et al. 2008;
Waldron et al. 2009; Caretta and Brito 2011). This method is a
modified classical PCR with a fluorescently labeled primer(s)
and is linked to the digestion of amplicons with restriction
enzyme(s). Only terminal fragments of PCR product contain-
ing fluorescent dye are visualized.
The aim of this study was to elaborate a method to differ-
entiate six Candida species using the PCR t-RFLP technique
based on a novel molecular target, the homocitrate synthase
gene. The homocitrate synthase gene encodes an enzyme in-
volved in the first reaction in the lysine biosynthesis pathway.
The protein is characteristic for fungi and several Archaea and
two isoforms are present for some Candida species. This gene
is considered as a good molecular target for chemotherapy of
disseminated fungal infections. It was the prerequisite for the
selection of this gene as a novel molecular target for Candida
species identification (Kur et al. 2010).
Materials and methods
Candida strains
In this study, the strains collection encompassed 75 clinical and
six reference strains ofCandida sp. The reference strainswere as
follows: C. albicans ATCC 64544, C. krusei ATCC 6258,
C. glabrata ATCC 2001, C. parapsilosis ATCC 22019,
C. tropicalisATCC 750, and C. dubliniensisATCCMYA-646.
Clinical strains were collected from patients of Public Hospital
No. 1 in Gdańsk, Poland and were identified according to the
routine laboratory procedure. Strains were isolated from blood
cultures (3), respiratory tract (28), urine (20), and genitourinary
tract (from swabs) (24). In case of patients with suspected
candidemia, blood was cultured using BacT/ALERT 3D
(bioMérieux) for about 5 days. The species identification proce-
dure involved subculture plates incubation on Sabouraud dex-
trose agar (SDA, bioMérieux), identification of isolated strains
on chromogenic media forCandida (CHROMagar®Candida),
and the biochemical panel VITEK® 2.
Culture and DNA isolation
Yeasts were cultivated in Sabouraud media with chloram-
phenicol (Emapol, Poland) for 24 h at 37 °C. The DNA iso-
lation from the single colony was performed using the
ExtractMe Purification Kit (Blirt DNA-Gdańsk, Poland), ac-
cording to the manufacturer’s recommended procedure. The
DNA concentration was measured using a NanoDrop ND-100
spectrophotometer (Thermo Fisher Scientific, Wilmington,
USA) and ranged from 10 to 60 ng per microliter.
PCR
Based on the homocitrate synthase gene sequences available
in the NCBI GenBank (C. albicans XM_708526,
XM_ 7 0 8 4 8 9 , XM_ 7 0 7 8 3 9 , C . d u b l i n i e n s i s
XM_002418342 , XM_002417072 , C. g labra ta
XM_447985, XM_448111, C. tropicalis XM_002547242,
XM_002550342, and C. parapsilosis HE605206-3,
HE605203), oligonucleotide primers for PCR reaction were
designed and their specificity was tested using, in both cases,
the BLAST sequence tool (NCBI Blast). There were no se-
quences for C. krusei available and these sequences were ob-
tained during this study (C. krusei KT_362370, KT_362371).
PCR reaction was carried out using the standard protocol at a
volume of 50 μL 0.2 mM of each dNTP (Blirt DNA-Gdańsk,
Poland), 2 mM of MgCl2 (Blirt DNA-Gdańsk, Poland), 4 μM
of each primer, the forward primer was labeled with fluores-
cein [5(6)FAM] at the 5′ end [LYSfor: 5′-5(6)FAM-
AGAGAAGGTGAACAATTTGC-3′ and LYSrev: 5′-CCAA
CAGTATCAGCAATACCAACTCT-3 ′ , Metabion ,
Germany], 1 U of Pfu Polymerase Hypernova (Blirt DNA-
Gdańsk, Poland), and 1 μL of fungal DNA. The reaction pro-
file was as follows: 94 °C for 120 s initial denaturation, 94 °C
for 30 s, 59 °C for 30 s, and 72 °C for 30 s for 30 cycles, and
then a final extension at 72 °C for 300 s.
Digestion of amplicons
Restriction analysis of each amplicon was carried out with
three endonucleases (Thermo Fisher Scientific, USA), RsaI,
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DraI, and BglII, as separate reactions. Restriction enzymes
were chosen using the NEBcutter tool (New England
Biolabs; http://tools.neb.com/NEBcutter/index.php3). They
were optimized to obtain the most differentiation potential
for distinguishing six Candida species using minimal types
of enzymes. Digestion of amplicons was carried out in
20 μL [15 μL of PCR sample, 2 μL of 10× reaction buffer
(Thermo Fisher Scientific, USA), 0.5 μL (2 U/μL) of
endonuclease, and 2.5 μL of water] for 40 min at 37 °C.
Digested products were separated by electrophoresis in
homemade 12% polyacrylamide gel. There was no ethidium
bromide in gel; therefore, only fluorescence from fluorescein-
labeled primers was observed in UV light.
Results and discussion
The technique that forms the basis of the described method
has become widely used in microbial community studies.
Molecular methods are especially useful for culture-difficult
and uncultivated microorganisms (Siqueira 2017). Microbial
diversity studies involving the t-RFLP method investigate not
only health and diseases influences (Jung et al. 2016), but also
industry issues (Hedrich 2016). The most commonly used
molecular targets are sequences within the ribosomal operon
(Hayashi et al. 2014). In contrary to the references in this
work, a novel application of the t-RFLP method is shown.
The selection of specific molecular targets other than ribosom-
al DNA and designing the method for species identification
shows the new potential of the t-RFLP method.
In this study, we apply the t-RFLP method for the identifi-
cation of the six medically important Candida species using
the universal primers for homocitrate synthase gene frag-
ments. The length of PCR products for all Candida tested
was 470 bp. It was established in silico using the NCBI
Primer Blast tool. A set of three restriction endonucleases
(RsaI, DraI, and BglII) for differentiation of the investigated
Candida species was chosen. Optimization of the number and
kind of enzymes was carried out based on the NEBCutter tool.
Two genes, LYS21 and LYS22, encoding isoforms of
homocitrate synthase, are present and, for each copy, we can
get a different pattern of digestion or not. The results of theo-
retical restriction patterns are presented in Table 1.
We have shown discriminatory power for these restriction
enzymes to distinguish the particular Candida species (Figs. 1
and 2). They have the potential for differentiation of six clin-
ically important Candida species. Additionally, the digestion
step can be modified for specific needs. Depending on how
many and which species must be identified, the optimal steps
of digestion by different enzymes and their order may be cho-
sen. For example, the identification of C. parapsilosis sensu
lato may be realized with only one BglII enzyme. In the case
of C. albicans and C. dubliniensis, two RsaI and DraI en-
zymes can be used for identification. The need to use all three
restriction enzymes is only applicable when all six of the in-
vestigated Candida species may be expected in a sample. The
presence of a 470-bp band indicates that there is a lack of
amplicon digestion. An appearance of another fragment inTable 1 Theoretical restriction fragments for Candida species. The
numbers in bold represent the first restriction fragments from the 5′ end
of the leading strand of polymerase chain reaction (PCR) products. These
fragments contain fluorescently 5′ labeled primer and are visualized in
electrophoresis. The other numbers represent the rest of the restriction
fragments obtained after the digestion of PCR products (they are not
visualized after electrophoresis). In some cases, there are two sets of
restriction patterns for one species. This appears when the DNA
sequences of enzyme isoschizomers gene polymorphism results in
different recognition site positions
Species Endonuclease
BglII (bp) RsaI (bp) DraI (bp)
C. albicans 470* 420*/50 161*/309
C. dubliniensis 470* 420*/50 161*/309
385*/85
C. tropicalis 470* 255*/164/51 161/309
385*/85
C. glabrata 470* 255*/193/22 470*
C. parapsilosis 470* 420*/50 470*
171*/299
C. krusei 470* 255*/164/51 161*/309
*Fragment labeled with fluorescence as a visible band on electrophoretic
gel
Fig. 1 Theoretical restriction patterns after electrophoresis for each
species. RsaI, BglII, and DraI are the restriction enzymes. Each icon
described in the legend represents one restriction enzyme, for which
restriction products that should appear in gel after electrophoresis are
visualized. The length of restriction products with fluorescently labeled
primers is represented by the y-axis
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the presence of a 470-bp band for the particular enzyme indi-
cates that the second copy of this gene has a restriction site.
The established diagnostic algorithm for reference strains
was confirmed with clinical strains (Fig. 3). All clinical strains
were identified correctly compared to results obtained using
CHROMagar. Clinical strains identified by the t-RFLP meth-
od and clinical sources are presented in Table 2. However,
very often, phenotyping methods like CHROMagar create
problems with determining the color and giving an accurate
identification, so choosing the appropriate therapy is impossi-
ble. All digestion reactions must be carried out in separate
tubes because simultaneous digestion with three endonucle-
ases in one reaction results in obtaining only the shortest prod-
uct, which does not identify the species. However, different
restriction patterns allows to mix reaction mixtures for all
three nucleases after digestion and separate such mixtures
using electrophoresis (C. albicans three bands 470, 420, and
161; C. dubliniensis four bands 470, 420, 385, and 161;
C. tropicalis three bands 470, 385, and 161; C. glabrata two
bands 470 and 255; C. parapsilosis three bands 470, 420, and
171; and C. krusei three bands 470, 255, and 161) (Fig. 1).
Digested products may also be separated by electrophoresis in
3–4% high-resolution agarose gel (agarose HiRes grade,
Bioline) for 90 min (7 V/cm), but the detection sensitivity
decreases and, therefore, more products of the digestion reac-
tion should be applied.
In this study, pure yeasts cultures growing on plate agar
were used. They were isolated from clinical samples. This fact
confirms that the described method is universal for the correct
identification of different strains of Candida and allows it to
be used as a diagnostic method in clinical laboratories.
Due to the specificity of primers in the PCR, simple detec-
tion method, and analyzing of the digestion products profile,
the t-RFLPmethod can probably be used for the identification
of Candida sp. from biological samples. However, further
validation is needed, because the sensitivity of PCR may
Fig. 2 Electropherogram of digestion products obtained for the six
reference Candida strains. Electrophoresis was carried out in 12%
polyacrylamide gel for 3 h (8 V/cm). There was no dye in the gel.
Visualization of DNA fragments was carried out in UV light. ND
polymerase chain reaction (PCR) product without digestion; RsaI,
BglII, and DraI are the patterns of digestion for restriction enzymes
Fig. 3 Representative electropherogram obtained for clinical strains of
Candida glabrata using the terminal restriction fragment length
polymorphism (t-RFLP) PCR method. Electrophoresis was carried out
in 12% polyacrylamide gel for 3 h (8 V/cm). There was no dye in the gel.
Visualization of DNA fragments was carried out in UV light. ND PCR
product without digestion of restriction enzyme(s); RCg C. glabrata
ATCC 2001 reference strain; Cg1, Cg2, Cg3, Cg4, Cg5 C. glabrata
clinical strains; RsaI, BglII, and DraI are the restriction enzymes
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decrease as a result of the inhibitors, e.g., in blood or sputum
(Al-Soud and Rådström 2001; Amicosante et al. 1995).
The sensitivity of the t-RFLP method is also dependent on
the restriction products detection method. Capillary electro-
phoresis is more sensitive than polyacrylamide gel electropho-
resis and a smaller amount of digested PCR products is need-
ed. It is also more precise and may be a good solution for
routine laboratory diagnostics because it can be automated
(Fawley et al. 2015).
Conclusions
In this study, a novel application for the terminal restriction
fragment length polymorphism (t-RFLP) method was devel-
oped. The results of this research lead to two main innovative
issues: new molecular target for the identification of Candida
species and showing the potential of the t-RFLP method for
diagnostic purposes. This method was successfully applied to
bacterial and yeast community investigations in different en-
vironments or microbiota analysis. In this study, the genotyp-
ing potential of the t-RFLP method has been extended to the
identification of Candida species. The results of this study
yield a novel tool for clinical diagnostics and highlights a
new path for the development of the t-RFLP method. The
designed method can be a cost-efficient, high-throughput mo-
lecular technique able to determine specific and simple restric-
tion patterns for the identification of six clinically important
Candida species.
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